Proinnovera Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 50

Employees

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 2

  • Investments
  • 1

Proinnovera General Information

Description

Operator of a contract research organization intended for the dermatology clinical trial space. The company offers various services such as medical writing, quality assurance, clinical monitoring, data management and biostatic services, and managing clinical trials (phase I to IV) for drugs and medical devices, thereby turning study data into oversight for clients to accelerate decision-making, increasing transparency and efficiency in the conduct of clinical trials.

Contact Information

Formerly Known As
Proverum
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Private Equity-Backed
Corporate Office
  • Wienburgstrasse 207
  • 48159 Muenster
  • Germany
Primary Industry
Other Pharmaceuticals and Biotechnology
Corporate Office
  • Wienburgstrasse 207
  • 48159 Muenster
  • Germany

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Proinnovera Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Proinnovera‘s full profile, request access.

Request a free trial

Proinnovera Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a contract research organization intended for the dermatology clinical trial space. The company offers vario
Other Pharmaceuticals and Biotechnology
Muenster, Germany
50 As of 2024

Raleigh, NC
 

Rockville, MD
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Proinnovera Competitors (11)

One of Proinnovera’s 11 competitors is Parexel International, a Private Equity-Backed company based in Raleigh, NC.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Parexel International Private Equity-Backed Raleigh, NC
The Emmes Company Private Equity-Backed Rockville, MD
North American Science Associates Private Equity-Backed Toledo, OH
CTI Clinical Trial and Consulting Private Equity-Backed Covington, KY
Cromos Pharma Corporation Dublin, Ireland
You’re viewing 5 of 11 competitors. Get the full list »

Proinnovera Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Proinnovera Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Proinnovera‘s full profile, request access.

Request a free trial

Proinnovera Investments (1)

Proinnovera’s most recent deal was a Buyout/LBO with Symbio Research. The deal was made on 10-Nov-2023.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Symbio Research 10-Nov-2023 Buyout/LBO Systems and Information Management
To view Proinnovera’s complete investments history, request access »

Proinnovera FAQs

  • When was Proinnovera founded?

    Proinnovera was founded in 2007.

  • Where is Proinnovera headquartered?

    Proinnovera is headquartered in Muenster, Germany.

  • What is the size of Proinnovera?

    Proinnovera has 50 total employees.

  • What industry is Proinnovera in?

    Proinnovera’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Proinnovera a private or public company?

    Proinnovera is a Private company.

  • What is Proinnovera’s current revenue?

    The current revenue for Proinnovera is .

  • Who are Proinnovera’s investors?

    TKL Research has invested in Proinnovera.

  • Who are Proinnovera’s competitors?

    Parexel International, The Emmes Company, North American Science Associates, CTI Clinical Trial and Consulting, and Cromos Pharma are some of the 11 competitors of Proinnovera.

  • When was Proinnovera acquired?

    Proinnovera was acquired on 17-Nov-2023.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process